You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Early exposure to the combined measles–mumps–rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder
|
---|---|
Published in |
Vaccine, January 2015
|
DOI | 10.1016/j.vaccine.2014.12.036 |
Pubmed ID | |
Authors |
Yota Uno, Tokio Uchiyama, Michiko Kurosawa, Branko Aleksic, Norio Ozaki |
Abstract |
This case-control study investigated the relationship between the risk of Autism Spectrum Disorder (ASD) onset, and early exposure to the combined Measles-Mumps-Rubella (MMR) vaccine and thimerosal consumption measured from vaccinations in the highly genetically homogenous Japanese population. |
X Demographics
The data shown below were collected from the profiles of 232 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 45 | 19% |
Saudi Arabia | 15 | 6% |
United Kingdom | 10 | 4% |
Italy | 9 | 4% |
Canada | 8 | 3% |
Spain | 8 | 3% |
Australia | 5 | 2% |
Germany | 4 | 2% |
France | 2 | <1% |
Other | 16 | 7% |
Unknown | 110 | 47% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 192 | 83% |
Scientists | 21 | 9% |
Practitioners (doctors, other healthcare professionals) | 15 | 6% |
Science communicators (journalists, bloggers, editors) | 4 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 254 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Italy | 1 | <1% |
Germany | 1 | <1% |
Canada | 1 | <1% |
Unknown | 250 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 64 | 25% |
Student > Master | 41 | 16% |
Researcher | 29 | 11% |
Other | 18 | 7% |
Student > Ph. D. Student | 16 | 6% |
Other | 49 | 19% |
Unknown | 37 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 60 | 24% |
Psychology | 31 | 12% |
Biochemistry, Genetics and Molecular Biology | 21 | 8% |
Nursing and Health Professions | 20 | 8% |
Agricultural and Biological Sciences | 16 | 6% |
Other | 61 | 24% |
Unknown | 45 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 351. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2024.
All research outputs
#93,849
of 25,746,891 outputs
Outputs from Vaccine
#128
of 16,620 outputs
Outputs of similar age
#913
of 361,639 outputs
Outputs of similar age from Vaccine
#2
of 143 outputs
Altmetric has tracked 25,746,891 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,620 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,639 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 143 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.